3611
Late Breaking Oral Abstract Session: Clinical/Translational Sciences
Sunday, March 6, 2016: 2:00 PM-3:15 PM
Convention Center, Level One, Petree Hall D
Oral Session
1.25 CME/CE
Primary Moderators:
Steve N. Georas , MD
Daniel J. Jackson , MD
2:00 PM
L58
The Skin Microbiome Differs with Age in Atopic Dermatitis
Baochen Shi, PhD
2:15 PM
L59
Enhanced Efficacy and Confirmed Safety of a Two-Year Epicutaneous Immunotherapy (EPIT) Treatment of Peanut Allergy with Viaskin® Peanut: The Continuation of the Vipes Phase IIb Randomized Controlled Trial (RCT)
Hugh A. Sampson, MD FAAAAI
2:30 PM
L60
The Efficacy of AR101, a Peanut-Derived Pharmaceutical for Oral Immunotherapy (OIT), Is Maintained and Tolerability Is Increased with Low-Dose Maintenance Therapy
J. Andrew Bird, MD, FAAAAI
2:45 PM
L61
Efficacy and Safety of the SQ-House Dust Mite Sublingual Immunotherapy Tablet in North American Children and Adults: Findings from a Large Randomized, Placebo-Controlled Clinical Trial
Hendrik Nolte, MD, PhD
3:00 PM
L62
Pathogenic Autoantibodies in Patients with Severe Asthma and Sputum Eosinophils
Manali Mukherjee, PhD